Why Dosage Differs by Age
Methotrexate dosage varies between children and adults primarily due to differences in body size, pharmacokinetics, and disease severity. Children have higher weight-normalized clearance rates, requiring higher mg/m² doses to achieve therapeutic blood levels equivalent to adults. Adults typically use fixed mg doses or lower mg/kg adjustments, reflecting slower metabolism and larger body mass.[1][2]
How Body Surface Area Guides Pediatric Dosing
Pediatric oncology and rheumatology protocols standardize methotrexate at 10-30 mg/m² IV or oral for acute lymphoblastic leukemia (ALL) maintenance, scaling to a child's smaller body surface area (BSA). For example, a 20 kg child might receive 200-600 mg per cycle, while an adult gets 20-50 mg weekly orally for rheumatoid arthritis (RA). BSA dosing prevents under- or overdosing in growing bodies.[3][4]
Pharmacokinetic Reasons for the Gap
Children metabolize methotrexate faster via renal and hepatic pathways, with clearance up to 2-3 times higher per kg than adults, driven by higher glomerular filtration rates and immature protein binding. This demands 3-5x higher relative doses in kids for equal exposure. Adults show prolonged half-life (6-8 hours vs. 2-4 in children), increasing toxicity risk at pediatric-equivalent rates.[1][5]
Disease-Specific Adjustments
- Cancer (e.g., ALL): Kids get high-dose pulses (1-5 g/m²) every 2-4 weeks; adults use lower 30-100 mg/m² for sarcomas or lymphomas.
- Rheumatoid Arthritis: Adults start at 7.5-15 mg weekly orally; juvenile idiopathic arthritis (JIA) in children uses 10-15 mg/m² weekly, capped at 25 mg max.[2][6]
- Ectopic Pregnancy: Adults receive single 50 mg/m² IM doses; not standard in children.[7]
Safety Factors and Monitoring
Higher pediatric doses raise risks like mucositis or myelosuppression, offset by leucovorin rescue and frequent folate supplementation. Adults monitor liver enzymes more for chronic low-dose toxicity. Age-based nomograms adjust for obesity or renal impairment.[4][8]
Common Dosage Examples
| Condition | Pediatric (mg/m²/week) | Adult (mg/week) |
|-----------|-------------------------|-----------------|
| JIA/RA | 10-15 | 7.5-25 |
| ALL Maintenance | 20-40 | N/A (rarely used) |
| High-Dose Cancer | 1,000-5,000/cycle | 500-12,000/cycle |
[1] Pharmacokinetics of Methotrexate in Children - PubMed
[2] Methotrexate Dosing Guidelines - American College of Rheumatology
[3] BSA Calculator and Pediatric Protocols - St. Jude Children's Research Hospital
[4] ALL Treatment Protocols - Children's Oncology Group
[5] Age-Dependent Methotrexate Clearance - Clinical Pharmacology & Therapeutics
[6] JIA Guidelines - Arthritis Foundation
[7] Ectopic Pregnancy Management - ACOG
[8] Methotrexate Toxicity Monitoring - FDA Label